Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership2,639 shares
Latest Disclosed Value $ 873,166
Walleye Capital LLC ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 2,639 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $753,962 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,968 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -55.78% during the quarter. The current value of the position is $687,460 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 3,600 of underlying shares valued at $1,191,132 USD and put options representing 5,900 of underlying shares valued at $1,952,133 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 2,639 -3,329 -55.78 873 -63.21 0.0036
2026-05-08 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,639 -3,329 873 0.0036
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,968 -16,377 -73.29 2,373 -76.71 0.0073
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 22,345 -16,370 -42.28 10,189 -19.29 0.0382
2025-08-13 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 38,715 36,345 1,533.54 12,625 1,875.59 0.0490
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,370 -17,746 -88.22 640 -86.50 0.0029
2025-02-13 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 20,116 16,467 451.27 4,733 371.88 0.0116
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,649 -66,658 -94.81 1,004 -94.13 0.0021
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 70,307 23,449 50.04 17,085 143.99 0.0305
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 46,858 22,044 88.84 7,003 47.44 0.0125
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 24,814 24,814 4,750 0.0101
2023-11-21 2023-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,040 -100.00 0 -100.00
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,040 0
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,040 1,040 198 0.0007
2022-05-27 2022-03-31 13F/A-01 ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -3,772 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -3,772 0
2022-05-27 2021-12-31 13F/A-01 ALNYLAM PHARMACEUTICALS COM 02043Q107 3,772 104 2.84 640 -7.65 0.0199
2022-03-03 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,772 104 640 0.0160
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,668 3,668 693 0.0196
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,870 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,870 1,870 215 0.0140
2019-08-14 2019-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -8,585 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,585 8,585 751 0.3505
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 3,600 28.57 1,191 7.01 n/a n/a n/a
2026-05-08 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 3,600 1,191 n/a n/a n/a
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,800 366.67 1,113 307.69 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 600 -53.85 274 -35.46 n/a n/a n/a
2025-08-13 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 1,300 -45.83 424 -34.72 n/a n/a n/a
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,400 -62.50 648 -56.94 n/a n/a n/a
2025-02-13 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 6,400 -58.44 1,506 -64.46 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 15,400 2,980.00 4,235 3,400.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 500 -90.74 122 -85.01 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 5,400 100.00 807 56.40 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,700 -71.58 517 -69.32 n/a n/a n/a
2023-11-21 2023-09-30 13F/A ALNYLAM PHARMACEUTICALS COM Call 9,500 331.82 1,682 303.36 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 9,500 1,682 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 2,200 -69.86 418 -71.48 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 7,300 2,333.33 1,462 1,959.15 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 300 71 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 5,700 533.33 656 811.11 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 900 -93.66 72 -93.01 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 14,200 54.35 1,030 19.77 n/a n/a n/a
2019-08-14 2019-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 9,200 860 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 9,200 860 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 5,900 -55.97 1,952 -63.36 n/a n/a n/a
2026-05-08 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 5,900 1,952 n/a n/a n/a
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 13,400 1,016.67 5,329 874.04 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,200 -40.00 547 -16.10 n/a n/a n/a
2025-08-13 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 2,000 -66.10 652 -59.07 n/a n/a n/a
2025-05-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 5,900 436.36 1,593 517.44 n/a n/a n/a
2025-02-13 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 1,100 -94.33 259 -95.16 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 19,400 5,336 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 1,400 -92.18 209 -93.90 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 17,900 62.73 3,426 75.87 n/a n/a n/a
2023-11-21 2023-09-30 13F/A ALNYLAM PHARMACEUTICALS COM Put 11,000 5,400.00 1,948 5,164.86 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,000 1,948 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 200 -95.35 38 -95.70 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,300 -28.33 861 -39.58 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 6,000 445.45 1,426 547.73 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,100 220 n/a n/a n/a
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 18,600 500.00 2,142 760.24 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 3,100 -40.38 249 -33.95 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 5,200 40.54 377 8.96 n/a n/a n/a
2019-08-14 2019-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 3,700 346 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 3,700 346 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.